APA (7th ed.) Citation

Wöckel, A., Park-Simon, T., Korfel, A., Raab, K., & Tesch, H. (2025). Preferences of patients with high-risk HR + /HER2- breast cancer for adjuvant endocrine treatment. Breast Cancer Research and Treatment, 211(1), 59-69. https://doi.org/10.1007/s10549-025-07622-9

Chicago Style (17th ed.) Citation

Wöckel, Achim, Tjoung-Won Park-Simon, Agnieszka Korfel, Kirsten Raab, and Hans Tesch. "Preferences of Patients with High-risk HR + /HER2- Breast Cancer for Adjuvant Endocrine Treatment." Breast Cancer Research and Treatment 211, no. 1 (2025): 59-69. https://doi.org/10.1007/s10549-025-07622-9.

MLA (9th ed.) Citation

Wöckel, Achim, et al. "Preferences of Patients with High-risk HR + /HER2- Breast Cancer for Adjuvant Endocrine Treatment." Breast Cancer Research and Treatment, vol. 211, no. 1, 2025, pp. 59-69, https://doi.org/10.1007/s10549-025-07622-9.